By Arthur Allen KFF Health News Don’t get Nathan Jones started on xylitol, the active ingredient in his chewing gum, nasal spray, and other products. He’ll talk your ear off about its wondrous powers against tooth decay, as well as its potential to fight covid, heart disease, Alzheimer’s — you name it. For now, Jones, […] The post FTC has long said products must back up health claims. A MAHA lawsuit would upend that. appeared first on North Carolina Health News.| North Carolina Health News
EVERSANA is merging with Waltz Health under the EVERSANA name. Mark Thierer, co-founder and CEO of Waltz Health, will serve as the CEO of the combined company. The post EVERSANA, Waltz Health Merge to Create $6B Prescription Drug Company appeared first on MedCity News.| MedCity News
As the cost of health care continues to rise and employers contemplate their upcoming health insurance renewals, glucagon-like peptide-1 (GLP-1) medications remain top of mind. While GLP-1 use is not new for conditions like diabetes or obesity, the utilization of these medications […] The post GLP-1s in Group Health Plans: What’s on the Watchlist appeared first on Word on Benefits.| Word on Benefits
President Trump has recently floated the idea of imposing tariffs of up to 250 percent on pharmaceuticals, with the intention of shifting pharmaceutical production to the US. These tariffs would not only drive drug prices higher but could also lead to shortages and reduce long-run drug innovation.| Tax Foundation
By Grace Vitaglione Some employers and health systems in North Carolina are looking to change how they manage prescription drug benefits for their employees. More employers are considering alternative pharmacy benefit managers — or PBMs — to run the drug benefits in their employees’ health insurance plan. For the past few years, the market has […] The post NC employers look to smaller PBMs without “shenanigans” appeared first on North Carolina Health News.| North Carolina Health News
Today's blog shares strategies for extended health coverage plans to consider as drug plan costs are projected to increase between 6% and 9%.| Word on Benefits
The pharmacy giant manages the prescription drug benefit for the State Health Plan, but contract negotiations are at an impasse.| North Carolina Health News
When encountering a public problem, people tend to fall into one of two camps: one camp, the larger one, says, "There oughta be a law." The other one asks, "How has the government created or aggravated the situation?" We know which camp Maestro Trump belongs to.| Free Association
State House, Senate pass legislation that would regulate pharmacy benefit managers, which manage prescription drug benefits for insurance companies.| North Carolina Health News
Compass Pathways has been aggressively using patent claims to corner the market on psychedelic-assisted treatments.| The American Prospect
On average, the new Medicare negotiated drug prices are 2.8 times the average of drug prices in 11 OECD countries of similar size and wealth.| Peterson-KFF Health System Tracker
In their ongoing quest to lower prescription drug prices, some states are forcing drugmakers to continue to sell cheaper medications to thousands of pharmacies through a federal drug-discount program.| Stateline
This chart collection explores how health spending is expected to grow in coming years. In 2024, per capita health spending growth is estimated to have slowed to 4.5%.| Peterson-KFF Health System Tracker
This analysis of survey data finds that over 40% of adults under 65 with private insurance could be indicated for a GLP-1 drug though relatively few have a claim, suggesting that a much smaller share seeks treatment through healthcare providers.| Peterson-KFF Health System Tracker
This analysis uses the Merative MarketScan 2022 commercial claims to estimate the number of enrollees in the employer-sponsored insurance market who use one or more of the ten drugs selected for Medicare Part D price negotiations.| Peterson-KFF Health System Tracker
The U.S. spends more on healthcare per capita than its peers. Most of the additional health spending goes to providers for inpatient and outpatient care.| Peterson-KFF Health System Tracker
Urban and rural communities have come to depend on pharmacies as a trusted care option and a place for advice.| AP News
An Associated Press analysis of licensing data from 44 states, data from the National Council for Prescription Drug Programs and the American Community Survey shows residents of neighborhoods that are majority Black and Latino have fewer pharmacies per capita than people who live in mostly white nei| AP News
Drugs solely approved to treat obesity have minimal to no coverage on most ACA Marketplace plans. Wegovy, a semaglutide approved for weight loss, is included in just 1% of Marketplace plans, while Ozempic, which has the same active ingredient but is approved for diabetes treatment and sometimes used off-label for weight loss, is included in 82% of Marketplace plan formularies. Among ACA Marketplace plans with these drugs on formulary, prior authorization is required by most plans. All plans ...| Peterson-KFF Health System Tracker
Although most adults are in good health and have health insurance, more than 1 in 4 adults (28%) reported delaying or foregoing healthcare due to cost.| Peterson-KFF Health System Tracker